TRIPS Council Next Step On Compulsory Licensing Is Meetings In October
Executive Summary
The next step for WTO's TRIPS Council in clarifying how developing countries without domestic manufacturing capacity can obtain pharmaceuticals through compulsory licensing will be a series of meetings held by the council's chair in October
You may also be interested in...
Trade Bill Pharmaceutical IP Provisions Could Impact Chile Negotiations
The impact of the intellectual property provisions of the fast-track trade bill will be tested in negotiations on economic pacts with Chile and Singapore
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials